30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Barinthus Biotherapeutics PLC (BRNS)

Track

The most recent insider trading activity occurred on June 26, 2023, with a BUY transaction by Joseph Scheeren. Prior to this, Robin Wright also made a BUY transaction on May 25, 2023. Earlier in the year, on March 27, 2023, William Enright executed a SELL transaction. Significant selling activity was observed in August 2022 by Christopher Ellis and Graham Griffiths.
Stock chart
Ticker: BRNS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Scheeren Joseph
1 purchase — total 24,400 USD
Buy 26 Jun 2023
Value US$3,306,075.41 | Price 226.61 | Shares 6,091
Buy 25 May 2023
Value US$4,845,816.67 | Price 478.44 | Shares 22,569
Sale 27 Mar 2023
Value US$36,298.50 | Price 2.42 | Shares 15,000
Sale 25 Aug 2022
Value US$176,707.50 | Price 7.07 | Shares 25,000
Sale 25 Aug 2022
Value US$80,688.37 | Price 5.69 | Shares 14,176
Sale 25 Aug 2022
Value US$73,870.00 | Price 7.39 | Shares 10,000
Sale 24 Aug 2022
Value US$2,152.22 | Price 4.78 | Shares 450
Sale 18 Aug 2022
Value US$10,530.92 | Price 4.84 | Shares 2,175
Sale 17 Aug 2022
Value US$3,092.74 | Price 4.77 | Shares 649
Sale 17 Aug 2022
Value US$2,381.00 | Price 4.76 | Shares 500
Sale 16 Aug 2022
Value US$5,876.37 | Price 4.82 | Shares 1,220
Sale 16 Aug 2022
Value US$10,513.14 | Price 4.78 | Shares 2,200
Sale 15 Aug 2022
Value US$11,407.20 | Price 4.75 | Shares 2,400
Sale 15 Aug 2022
Value US$25,463.32 | Price 4.76 | Shares 5,350
Sale 12 Aug 2022
Value US$22,500.00 | Price 4.50 | Shares 5,000
Sale 28 Jun 2022
Value US$30.00 | Price 6.00 | Shares 5
Sale 23 Jun 2022
Value US$42.24 | Price 5.28 | Shares 8
Buy 1 Apr 2022
Value US$50,900.00 | Price 5.09 | Shares 10,000
Buy 31 Mar 2022
Value US$10,280.00 | Price 5.14 | Shares 2,000
Buy 31 Dec 2021
Value US$10,860.00 | Price 10.86 | Shares 1,000
Buy 22 Dec 2021
Value US$99,700.00 | Price 9.97 | Shares 10,000
Buy 4 May 2021
Value US$51,000.00 | Price 17.00 | Shares 3,000
Buy 4 May 2021
Value US$28,900.00 | Price 17.00 | Shares 1,700
Buy 4 May 2021
Value US$51,000.00 | Price 17.00 | Shares 3,000
Buy 4 May 2021
Value US$10,200,000.00 | Price 17.00 | Shares 600,000
Buy 30 Apr 2021
Value US$1,800,000.00 | Price 14.40 | Shares 125,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-28 2023-06-26 B Purchase
Scheeren Joseph
Non-Executive Director
6,091 -25.3%
226.61
US$3,306,075 		6,091 -25.3% 226.61 US$3,306,075
2023-06-01 2023-05-25 B Purchase
Wright Robin
Non-Executive Director
22,569 +17.7%
478.44
US$4,845,817 		22,569 +17.7% 478.44 US$4,845,817
2023-03-29 2023-03-27 S Sale
0.7
Enright William

Chief Executive Officer

Executive Director
5,740 +43.8%
118.49
US$4,293,377 		5,740 +43.8% 118.49 US$4,293,377
2022-08-26 2022-08-25 S Sale
Ellis Christopher

Chief Operating Officer

Officer
25,000 -99.7%
7.07
US$176,708 		25,000 -99.7% 7.07 US$176,708
2022-08-26 2022-08-25 S Sale
Ellis Christopher

Chief Operating Officer

Officer
14,176 -36.1%
5.69
US$80,688 		14,176 -36.1% 5.69 US$80,688
2022-08-26 2022-08-25 S Sale
Griffiths Graham

Chief Business Officer

Officer
10,000 -8.8%
7.39
US$73,870 		10,000 -8.8% 7.39 US$73,870
2022-08-26 2022-08-24 S Sale
Ellis Christopher

Chief Operating Officer

Officer
450 -85.7%
4.78
US$2,152 		450 -85.7% 4.78 US$2,152
2022-08-19 2022-08-18 S Sale
Ellis Christopher

Chief Operating Officer

Officer
2,175 -96.7%
4.84
US$10,531 		2,175 -96.7% 4.84 US$10,531
2022-08-19 2022-08-17 S Sale
Ellis Christopher

Chief Operating Officer

Officer
649 -89.6%
4.77
US$3,093 		649 -89.6% 4.77 US$3,093
2022-08-19 2022-08-17 S Sale
Griffiths Graham

Chief Business Officer

Officer
500 -0.4%
4.76
US$2,381 		500 -0.4% 4.76 US$2,381
2022-08-17 2022-08-16 S Sale
Griffiths Graham

Chief Business Officer

Officer
1,220 -1.1%
4.82
US$5,876 		1,220 -1.1% 4.82 US$5,876
2022-08-17 2022-08-16 S Sale
Ellis Christopher

Chief Operating Officer

Officer
2,200 -96.7%
4.78
US$10,513 		2,200 -96.7% 4.78 US$10,513
2022-08-17 2022-08-15 S Sale
Griffiths Graham

Chief Business Officer

Officer
2,400 -2.0%
4.75
US$11,407 		2,400 -2.0% 4.75 US$11,407
2022-08-17 2022-08-15 S Sale
Ellis Christopher

Chief Operating Officer

Officer
5,350 -98.6%
4.76
US$25,463 		5,350 -98.6% 4.76 US$25,463
2022-08-15 2022-08-12 S Sale
Griffiths Graham

Chief Business Officer

Officer
5,000 -4.1%
4.50
US$22,500 		5,000 -4.1% 4.50 US$22,500
2022-07-15 2022-06-28 S Sale
Ellis Christopher

Chief Operating Officer

Officer
5 -6.2%
6.00
US$30 		5 -6.2% 6.00 US$30
2022-07-15 2022-06-23 S Sale
Griffiths Graham

Chief Business Officer

Officer
8 -0.0%
5.28
US$42 		8 -0.0% 5.28 US$42
2022-04-04 2022-04-01 B Purchase
Scheeren Joseph
Non-Executive Director
10,000 +333.3%
5.09
US$50,900 		10,000 +333.3% 5.09 US$50,900
2022-04-04 2022-03-31 B Purchase
Hammacher Alex
Non-Executive Director
2,000 +200.0%
5.14
US$10,280 		2,000 +200.0% 5.14 US$10,280
2022-01-04 2021-12-31 B Purchase
Hammacher Alex
Non-Executive Director
1,000 +inf%
10.86
US$10,860 		1,000 +inf% 10.86 US$10,860
2021-12-23 2021-12-22 B Purchase
Wright Robin
Non-Executive Director
10,000 +40.8%
9.97
US$99,700 		10,000 +40.8% 9.97 US$99,700
2021-05-06 2021-05-04 B Purchase
Scheeren Joseph
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
2.5
DAWES KAREN A
Non-Executive Director
1,700 +inf%
17.00
US$28,900 		1,700 +inf% 17.00 US$28,900
2021-05-06 2021-05-04 B Purchase
Phillips Anne M.
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
Oxford Sciences Innovation plc
Large shareholder
600,000 +7.3%
17.00
US$10,200,000 		600,000 +7.3% 17.00 US$10,200,000
2021-05-03 2021-04-30 B Purchase
3.6
M&G INVESTMENT MANAGEMENT LTD
Large shareholder
125,000 +13.0%
14.40
US$1,800,000 		125,000 +13.0% 14.40 US$1,800,000
Explore more

More insider trading research around Barinthus Biotherapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America